SNAP-29
Half-Life (t½) TD: 6h
Formula C21H37N9O5
Molecular Weight 495.6 g/mol
Aliases Vialox Pharmacological Mechanism Cosmetic peptide — competitive nicotinic ACh receptor antagonist on facial muscle motor endplates. Same "Botox-in-a-jar" class as argireline; even more reduction-of-expression-line claim with sparse rigorous evidence.
Half-Life & Elimination Curve (TD: 6h) 100% 50% 25% 12.5% 0% 0h 0×t½ 6h 1×t½ 12h 2×t½ 18h 3×t½ 24h 4×t½ 30h 5×t½ 0×t½ (0h): 100% remaining 1×t½ (6h): 50% remaining 2×t½ (12h): 25% remaining 3×t½ (18h): 12.5% remaining 4×t½ (24h): 6.3% remaining 5×t½ (30h): 3.1% remaining Elimination (TD)
0×t½ 0h 100% 1×t½ 6h 50% 2×t½ 12h 25% 3×t½ 18h 12.5% 4×t½ 24h 6.3% 5×t½ 30h 3.1% Dosing Guidelines Transdermal (TD): Typical 2 mg (Range: 0.5–5 mg)Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: BYWJFRMLHFQWSR-UHFFFAOYSA-NSMILES: CC(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C2CCCN2C(=O)CNDirectory Compounds Registry Human Biology Hub